Trials / Completed
CompletedNCT04366323
Clinical Trial to Assess the Safety and Efficacy of Intravenous Administration of Allogeneic Adult Mesenchymal Stem Cells of Expanded Adipose Tissue in Patients With Severe Pneumonia Due to COVID-19
Phase I / II Clinical Trial, Multicenter, Randomized and Controlled, to Assess the Safety and Efficacy of Intravenous Administration of Allogeneic Adult Mesenchymal Stem Cells of Expanded Adipose Tissue in Patients With Severe Pneumonia Due to COVID-19
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 26 (actual)
- Sponsor
- Andalusian Network for Design and Translation of Advanced Therapies · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Phase I/II clinical trial to evaluate the safety and efficacy of Allogenic Adipose Tissue-Derived Mesenchymal Stem Cells Expanded in patients with severe COVID-19 pneumonia
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ALLOGENEIC AND EXPANDED ADIPOSE TISSUE-DERIVED MESENCHYMAL STEM CELLS | Two doses of 80 million adipose-tissue derived mesenchymal stem cells |
Timeline
- Start date
- 2020-04-27
- Primary completion
- 2021-12-30
- Completion
- 2021-12-30
- First posted
- 2020-04-28
- Last updated
- 2022-04-06
Locations
6 sites across 1 country: Spain
Source: ClinicalTrials.gov record NCT04366323. Inclusion in this directory is not an endorsement.